A patient of mine — a physician herself — had a hysterectomy and started transdermal estradiol a few weeks later. Then her breasts began to ache. Not a little. Enough that a seatbelt hurt. Enough that she lay awake at 2 a.m. reading about estrogen and breast cancer and arrived in my office certain she had done something dangerous to her own body. She is a trained clinician. She has read papers. And she was still terrified. That tells you something about how thoroughly one 2002 press conference reshaped what an entire generation of women — including the ones with medical degrees — believe about estrogen. So let's go back to what the Women's Health Initiative actually found. Not the headline. The data.

I have a three-page handout I give to women who want to try testosterone. It exists because there is no other way to do this. It tells them that the medication I am prescribing has no FDA-approved version for their sex, anywhere in this country. It tells them insurance will almost certainly not cover it, and to budget roughly $130 out of pocket. It tells them to ignore the instructions printed on the pharmacy label, because those instructions were written for a 200-pound man and following them would deliver roughly ten times the dose I intend. It tells them to squeeze out a pea-sized amount of gel — about half a gram — from a packet designed to be emptied in one application, and to make that packet last ten days.

For twenty years, women have been handed the same phrase: use the lowest effective dose of hormone therapy. It appears in visit notes, pharmacy leaflets, and patient handouts. It has become clinical shorthand. The phrase isn't wrong. But the shorthand quietly dropped the most important half of it — and for midlife women whose real concern is their skeleton, that missing half matters enormously.